CIAS
TGTX icon

CBIZ Investment Advisory Services’s TG Therapeutics TGTX Stock Holding History

CBIZ Investment Advisory Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$7.2K – 786
2025
Q2 		$7.2K Hold
200
– – ﹤0.01% 395
2025
Q1 		$7.89K Hold
200
– – ﹤0.01% 345
2024
Q4 		$6.02K Buy
+200
New +$5.74K ﹤0.01% 311

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CBIZ Investment Advisory Services's TGTX Position: Q3 2025 in Review

CBIZ Investment Advisory Services sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 200 shares — an estimated $7.2K sold.

CBIZ Investment Advisory Services first reported a position in TGTX in Q4 2024 and held it in 3 quarters. The position peaked at $7.89K in Q1 2025. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • CBIZ Investment Advisory Services reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 200 TG Therapeutics shares in Q3 2025, an estimated $7.2K.
  • CBIZ Investment Advisory Services first reported a position in TG Therapeutics in Q4 2024 and held it in 3 quarters.
  • CBIZ Investment Advisory Services's TG Therapeutics position peaked at $7.89K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on CBIZ Investment Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.